Screening Novel Agent Combinations to Expedite CTCL Therapeutic Development

Published: 19 April 2020| Version 1 | DOI: 10.17632/hpvnkrshdg.1
Contributor:
Fatima Mirza

Description

High-throughput screening on patient-derived malignant cutaneous T cell lymphoma cells.

Files

Institutions

Yale University

Categories

Dermatology, Oncology

Licence